Main Session
Sep
30
SH 05 - Genitourinary Cancer - Science Highlights
311 - Germline Biomarker for Late Genitourinary Adverse Events after Radiotherapy for Prostate Cancer: Validation in Multiple Prospective Trials
Presenter(s)
Amar Kishan, MD - UCLA, Culver City, California